Non-Canonical Kinases and Substrates in Cancer Progression by Francisco M. Vega

Get full text

The C/H3 domain of p300 is required to protect VRK1 and VRK2 from their downregulation induced by p53. by Alberto Valbuena, Sandra Blanco, Francisco M Vega, Pedro A Lazo

Get full text

RhoB regulates cell migration through altered focal adhesion dynamics by Francisco M. Vega, Audrey Colomba, Nicolas Reymond, Mairian Thomas, Anne J. Ridley

Get full text

A protocol to enrich in undifferentiated cells from neuroblastoma tumor tissue samples and cell lines by Aida Amador-Álvarez, María A. Gómez-Muñoz, Ismael Rodríguez-Prieto, Ricardo Pardal, Francisco M. Vega

Get full text

Response to “High CD44 expression is not a prognosis marker in patients with high-risk neuroblastoma” by Francisco M. Vega, Ana Colmenero-Repiso, María A. Gómez-Muñoz, Ismael Rodríguez-Prieto, Diana Aguilar-Morante, Gema Ramírez, Catalina Márquez, Rosa Cabello, Ricardo Pardal

Get full text

Corrigendum to ‘CD44-high neural crest stem-like cells are associated with tumour aggressiveness and poor survival in neuroblastoma tumours’ [EBioMedicine 49 (2019) 82–95] by Francisco M. Vega, Ana Colmenero-Repiso, María A. Gómez-Muñoz, Ismael Rodríguez-Prieto, Diana Aguilar-Morante, Gema Ramírez, Catalina Márquez, Rosa Cabello, Ricardo Pardal

Get full text

Analysis of Serial Neuroblastoma PDX Passages in Mice Allows the Identification of New Mediators of Neuroblastoma Aggressiveness by María A. Gómez-Muñoz, Diana Aguilar-Morante, Ana Colmenero-Repiso, Aida Amador-Álvarez, Mónica Ojeda-Puertas, Juan Antonio Cordero Varela, Ismael Rodríguez-Prieto, Ricardo Pardal, Francisco M. Vega

Get full text

Identification of VRK1 as a New Neuroblastoma Tumor Progression Marker Regulating Cell Proliferation by Ana Colmenero-Repiso, María A. Gómez-Muñoz, Ismael Rodríguez-Prieto, Aida Amador-Álvarez, Kai-Oliver Henrich, Diego Pascual-Vaca, Konstantin Okonechnikov, Eloy Rivas, Frank Westermann, Ricardo Pardal, Francisco M. Vega

Get full text